- Artificial ventilation systems, providing mechanical respiratory support to patients with compromised lung function, are increasingly vital components in modern critical care settings across hospitals, ambulatory centers, and home care environments due to their life-saving role, technological advancements, and adaptability to both invasive and non-invasive applications
- The escalating demand for artificial ventilation is primarily fueled by the rising prevalence of chronic respiratory conditions such as COPD and asthma, increased intensive care admissions, and the growing need for emergency preparedness following global respiratory outbreaks
- North America dominated the artificial ventilation market with the largest revenue share of 35.5% in 2024, characterized by advanced healthcare infrastructure, high healthcare spending, and the presence of major market players, with the U.S. witnessing strong growth in ventilator adoption across critical care units and home-based care, driven by innovation in portable and AI-integrated ventilators
- Asia-Pacific is expected to be the fastest growing region in the artificial ventilation market during the forecast period due to improving healthcare systems, increasing awareness of respiratory care, and expanding access to medical technology
- Constant volume type segment dominated the artificial ventilation market with a market share of 60.5% in 2024, driven by its precise control over tidal volume delivery and consistent performance in managing critically ill patients in intensive care settings
